Global Health Limited

Global Health Limited (MEDANTA) is a mid-cap Healthcare company valued at ₹33,362 crore operating in Hospital on the NSE and BSE.

Recent price move

Global Health Limited last traded at ₹1,238.6, down 2.89% on the day.

Recent developments

On 2026-06-25, HDFC Mutual Fund purchased 10 lakh shares of Global Health for ₹130 crore from co-founder Sunil Sachdeva, indicating continued confidence in the company's growth. On 2026-06-23, the company announced an Analyst/Investor Meet, showing engagement with stakeholders.

Financial performance

The company's business is growing, with annual revenue rising 19.5% and annual net profit increasing 15.2%. However, the net profit margin narrowed by 0.5 percentage points to 12.6%, while the latest quarter showed revenue rising 26.5% but net profit falling 1.1% compared to the same quarter a year earlier.

Valuation multiples

The stock trades at 59.8 times earnings, a premium to the Healthcare median of 32.0, 9.91 times book value. It yields 0.0%.

Things to watch

The stock is 15.0% below its 52-week high, and the net profit margin has declined by 0.5 percentage points, which could signal pressure on profitability. The latest quarter's net profit fell 1.1% compared to the same quarter a year earlier, despite higher revenue.

Where it stands

Global Health Limited has shown strong revenue growth over the past five years, with a 25.0% CAGR, and its latest quarter revenue rose 26.5% year-over-year. The stock is currently 15.0% below its 52-week high, and the net profit margin has narrowed slightly to 12.6%.

Summarised by DocStoX's model on 2026-10-10 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.